Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Avila Therapeutics

A biotechnology company focused on developing covalent drugs for the treatment of cancer and other autoimmune diseases

Overview Structured Data Issues Contributors Activity

avilatx.com

Is a

Organization

Company

Company attributes

Industry

Pharmaceutical industry

Technology

Biotechnology

Consumer biotechnology

Autoimmune disease

Biology

Location

New York

Waltham, Massachusetts

New York City

AngelList URL

angel.co/avila-therapeutics

Pitchbook URL

pitchbook.com/profiles.../51400-99

Phone Number

+18003322056

+18003211335

+18007215072

Full Address

430 E. 29th Street, 14th Floor, New York, NY 10016

Investors

Clovis Oncology

Founded Date

2006

Total Funding Amount (USD)

4,000,000

Latest Funding Round Date

January 20, 2012

Acquisition Transaction

‌

Acquisition of Avila Therapeutics by Celgene

Patents Assigned (Count)

Wellfound ID

avila-therapeutics

Country

United States

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Avila Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API